Cancer is the most common indication for computed tomography (CT) exams today. It is therefore clinically and financially essential for a successful CT facility to provide a fast and efficient oncology workflow in combination with the highest possible diagnostic accuracy. Critical questions like: “Did we find all lesions?”, “Is the cancer progressing or regressing?”, and “Does the cancer respond to the therapy?” need fast and reliable answers. Only the most innovative CT technologies such as Siemens z-SharpTM technology in combination with robust, clinically validated applications such as syngo® CT Oncology can fulfil these requirements.
___________________________
[1] RECIST: Response Evaluation Criteria in Solid Tumors
[2] WHO: World Health Organization
[3] ACRIN: American College of Radiology Imaging Network